This study represents a novel individualized therapeutic approach in brain metastases, a disease with a critical need for effective therapy. Support: U10CA180821, U10CA180882, https://acknowledgments.alliancefound.org; Genentech, Kazia Therapeutics Limited, Eli Lilly; Clinical trial information: NCT03994796.
We are the minno in with the big fish and PB has moved the goal post and given us the lion shares of the patients to boot.
- Forums
- ASX - By Stock
- KZA
- Across the pond...Nasdaq: KZIA
Across the pond...Nasdaq: KZIA, page-159
-
- There are more pages in this discussion • 112 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add KZA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online